May 12, 2026 — Johnson & Johnson has launched its Shockwave C2 Aero Coronary IVL catheter designed for improved ...
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...
May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 1, 2026 — Echo IQ recently announced it has deployed its AI-based decision support software for the assessment of ...
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
May 1, 2026 — Retia Medical recently announced the first public presentation of results from its non-invasive cardiac ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...
The clinical case for combining CT and angiography in a single workflow has been settled. Purpose-built mobile imaging ...
May 4, 2026 — Johnson & Johnson recently announced new data from a novel U.S. pilot single-arm trial that evaluated the ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 4, 2026 — A new guideline from the American Society of Echocardiography (ASE) provides guidance for cardiovascular ...
Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...
April 29, 2026 — Agitated Solutions, Inc.(ASI) has received CE Mark approval in the European Union for its novel device ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Editor's Note: This is Part Two of a three-part series highlighting several of the presentations from the American ...
April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...
April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...
May 12, 2026
